Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antirheumatics Pharmaceutical refers to drugs that can treat rheumatism, such as non-steroidal anti-inflammatory drugs, steroidal anti-inflammatory drugs, etc.
The report details the trend, potential and market size of Antirheumatics Pharmaceutical market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antirheumatics Pharmaceuticalmarket, defines the market attractiveness level of Antirheumatics Pharmaceutical market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antirheumatics Pharmaceutical industry, describes the types of Antirheumatics Pharmaceutical market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antirheumatics Pharmaceutical market and the development prospects and opportunities of Antirheumatics Pharmaceutical industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antirheumatics Pharmaceutical market in Chapter 13.
By Player:
Novartis International AG
Roche Holding AG
AbbVie
Bristol-Myers Squibb
Johnson & Johnson
Merck
Pfizer
Eli Lilly and Company
Amgen
UCB SA
By Type:
Non-Steroidal Anti-Inflammatory Drugs
Steroidal Anti-Inflammatory Drugs
Slow Acting Drug
Immunological Preparation
By End-User:
Pharmaceutical Industry
Hospital and Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antirheumatics Pharmaceutical Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antirheumatics Pharmaceutical Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antirheumatics Pharmaceutical Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antirheumatics Pharmaceutical Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antirheumatics Pharmaceutical Market Analysis and Outlook to 2022
-
7.1 Global Antirheumatics Pharmaceutical Consumption (2017-2022)
-
7.2 United States Antirheumatics Pharmaceutical Consumption (2017-2022)
-
7.3 Europe Antirheumatics Pharmaceutical Consumption (2017-2022)
-
7.4 China Antirheumatics Pharmaceutical Consumption (2017-2022)
-
7.5 Japan Antirheumatics Pharmaceutical Consumption (2017-2022)
-
7.6 India Antirheumatics Pharmaceutical Consumption (2017-2022)
-
7.7 South Korea Antirheumatics Pharmaceutical Consumption (2017-2022)
8 Region and Country-wise Antirheumatics Pharmaceutical Market Analysis and Outlook to 2028
-
8.1 Global Antirheumatics Pharmaceutical Consumption Forecast (2022-2028)
-
8.2 United States Antirheumatics Pharmaceutical Consumption Forecast (2022-2028)
-
8.3 Europe Antirheumatics Pharmaceutical Consumption Forecast (2022-2028)
-
8.4 China Antirheumatics Pharmaceutical Consumption Forecast (2022-2028)
-
8.5 Japan Antirheumatics Pharmaceutical Consumption Forecast (2022-2028)
-
8.6 India Antirheumatics Pharmaceutical Consumption Forecast (2022-2028)
-
8.7 South Korea Antirheumatics Pharmaceutical Consumption Forecast (2022-2028)
9 Global Antirheumatics Pharmaceutical Market Outlook by Types and Applications to 2022
-
9.1 Global Antirheumatics Pharmaceutical Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Slow Acting Drug Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Immunological Preparation Consumption and Growth Rate (2017-2022)
-
9.2 Global Antirheumatics Pharmaceutical Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharmaceutical Industry Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital and Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antirheumatics Pharmaceutical Market Outlook by Types and Applications to 2028
-
10.1 Global Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Non-Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Slow Acting Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Immunological Preparation Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pharmaceutical Industry Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital and Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antirheumatics Pharmaceutical Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antirheumatics Pharmaceutical Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antirheumatics Pharmaceutical Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antirheumatics Pharmaceutical Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antirheumatics Pharmaceutical Market Competitive Analysis
-
14.1 Novartis International AG
-
14.1.1 Novartis International AG Company Details
-
14.1.2 Novartis International AG Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis International AG Antirheumatics Pharmaceutical Product and Service
-
14.2 Roche Holding AG
-
14.2.1 Roche Holding AG Company Details
-
14.2.2 Roche Holding AG Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Holding AG Antirheumatics Pharmaceutical Product and Service
-
14.3 AbbVie
-
14.3.1 AbbVie Company Details
-
14.3.2 AbbVie Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AbbVie Antirheumatics Pharmaceutical Product and Service
-
14.4 Bristol-Myers Squibb
-
14.4.1 Bristol-Myers Squibb Company Details
-
14.4.2 Bristol-Myers Squibb Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bristol-Myers Squibb Antirheumatics Pharmaceutical Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Antirheumatics Pharmaceutical Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Antirheumatics Pharmaceutical Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Antirheumatics Pharmaceutical Product and Service
-
14.8 Eli Lilly and Company
-
14.8.1 Eli Lilly and Company Company Details
-
14.8.2 Eli Lilly and Company Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly and Company Antirheumatics Pharmaceutical Product and Service
-
14.9 Amgen
-
14.9.1 Amgen Company Details
-
14.9.2 Amgen Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amgen Antirheumatics Pharmaceutical Product and Service
-
14.10 UCB SA
-
14.10.1 UCB SA Company Details
-
14.10.2 UCB SA Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 UCB SA Antirheumatics Pharmaceutical Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antirheumatics Pharmaceutical
-
Figure Antirheumatics Pharmaceutical Picture
-
Table Global Antirheumatics Pharmaceutical Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antirheumatics Pharmaceutical Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antirheumatics Pharmaceutical Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antirheumatics Pharmaceutical Consumption by Country (2017-2022)
-
Figure United States Antirheumatics Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Table Europe Antirheumatics Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure China Antirheumatics Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Japan Antirheumatics Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure India Antirheumatics Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antirheumatics Pharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Antirheumatics Pharmaceutical Consumption Forecast by Country (2022-2028)
-
Figure United States Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antirheumatics Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Steroidal Anti-Inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Slow Acting Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Immunological Preparation Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Industry Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital and Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroidal Anti-Inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Slow Acting Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunological Preparation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Industry Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital and Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antirheumatics Pharmaceutical Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antirheumatics Pharmaceutical Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis International AG (Foundation Year, Company Profile and etc.)
-
Table Novartis International AG Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International AG Antirheumatics Pharmaceutical Product and Service
-
Table Roche Holding AG (Foundation Year, Company Profile and etc.)
-
Table Roche Holding AG Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holding AG Antirheumatics Pharmaceutical Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Antirheumatics Pharmaceutical Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antirheumatics Pharmaceutical Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Antirheumatics Pharmaceutical Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Antirheumatics Pharmaceutical Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antirheumatics Pharmaceutical Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Antirheumatics Pharmaceutical Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Antirheumatics Pharmaceutical Product and Service
-
Table UCB SA (Foundation Year, Company Profile and etc.)
-
Table UCB SA Antirheumatics Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB SA Antirheumatics Pharmaceutical Product and Service
-
